These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1333012)

  • 41. Receptor antagonism of leukotriene B4 myotropic activity by the 2,6 disubstituted pyridine analog U-75302: characterization on lung parenchyma strips.
    Lawson CF; Wishka DG; Morris J; Fitzpatrick FA
    J Lipid Mediat; 1989; 1(1):3-12. PubMed ID: 2562431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. o-phenylphenols: potent and orally active leukotriene B4 receptor antagonists.
    Sofia MJ; Floreancig P; Bach NJ; Baker SR; Cockerham SL; Fleisch JH; Froelich LL; Jackson WT; Marder P; Roman CR
    J Med Chem; 1993 Nov; 36(24):3978-81. PubMed ID: 7902871
    [No Abstract]   [Full Text] [Related]  

  • 43. Specific binding of leukotriene B4 to guinea pig lung membranes.
    Saad M; Wong K
    Biochem Biophys Res Commun; 1987 Feb; 143(1):364-71. PubMed ID: 3030320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New serine protease inhibitors with leukotriene B4 (LTB4) receptor binding affinity.
    Nakayama Y; Senokuchi K; Sakaki K; Kato M; Maruyama T; Miyazaki T; Ito H; Nakai H; Kawamura M
    Bioorg Med Chem; 1997 May; 5(5):971-85. PubMed ID: 9208106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors.
    Clancy RM; Dahinden CA; Hugli TE
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5729-33. PubMed ID: 6091105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leukotriene B4 costimulates 5-lipoxygenase activity in neutrophils via increased 5-lipoxygenase translocation.
    Serio KJ; Baker JR; Ring WL; Riddick CA; Bigby TD
    Am J Physiol; 1997 Apr; 272(4 Pt 1):C1329-34. PubMed ID: 9142859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 2. Effects of an additional phenyl ring on receptor affinity.
    Huang FC; Galemmo RA; Johnson WH; Poli GB; Morrissette MM; Mencel JJ; Warus JD; Campbell HF; Nuss GW; Carnathan GW
    J Med Chem; 1990 Apr; 33(4):1194-200. PubMed ID: 2157010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The design and synthesis of second generation leukotriene B4 (LTB4) receptor antagonists related to SC-41930.
    Penning TD; Djuric SW; Docter SH; Yu SS; Spangler D; Anglin CP; Fretland DJ; Kachur JF; Keith RH; Tsai BS
    Agents Actions; 1993; 39 Spec No():C11-3. PubMed ID: 8273545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.
    Pettipher ER; Salter ED; Breslow R; Raycroft L; Showell HJ
    Br J Pharmacol; 1993 Sep; 110(1):423-7. PubMed ID: 8220903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate.
    Hullot P; Poudrel JM; Muller A; Escale R; Rossi JC; Girard JP; Bonne C
    Arzneimittelforschung; 1997 Jan; 47(1):51-8. PubMed ID: 9037445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 1. Structure-activity relationships of the benzophenone nucleus.
    Gapinski DM; Mallett BE; Froelich LL; Jackson WT
    J Med Chem; 1990 Oct; 33(10):2798-807. PubMed ID: 2170647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Omega-[(omega-arylalkyl)aryl]alkanoic acids: a new class of specific LTA4 hydrolase inhibitors.
    Labaudinière R; Hilboll G; Leon-Lomeli A; Lautenschläger HH; Parnham M; Kuhl P; Dereu N
    J Med Chem; 1992 Aug; 35(17):3156-69. PubMed ID: 1324315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of leukotriene B4 to airway inflammation and the effect of antagonists.
    Richards IM; Sun FF; Taylor BM; Shields SK; Griffin RL; Morris J; Wishka DG; Smith HW; Johnson RA; Dunn CJ
    Ann N Y Acad Sci; 1991; 629():274-87. PubMed ID: 1659282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the uptake, binding and metabolism of leukotriene B4 by human neutrophils.
    Brom J; König W
    Immunology; 1989 Dec; 68(4):479-85. PubMed ID: 2558070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flow cytometric evaluation of the effects of leukotriene B4 receptor antagonists (LY255283 and SC-41930) on calcium mobilization and integrin expression of activated human neutrophils.
    Marder P; Schultz RM; Spaethe SM; Sofia MJ; Herron DK
    Prostaglandins Leukot Essent Fatty Acids; 1992 Aug; 46(4):265-70. PubMed ID: 1329112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils.
    Sehmi R; Rossi AG; Kay AB; Cromwell O
    Immunology; 1992 Sep; 77(1):129-35. PubMed ID: 1328044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonists.
    Greenspan PD; Fujimoto RA; Marshall PJ; Raychaudhuri A; Lipson KE; Zhou H; Doti RA; Coppa DE; Zhu L; Pelletier R; Uziel-Fusi S; Jackson RH; Chin MH; Kotyuk BL; Fitt JJ
    J Med Chem; 1999 Jan; 42(1):164-72. PubMed ID: 9888841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of leukotriene-B4 receptor antagonist, SC-41930, on acetic acid-induced colonic inflammation.
    Fretland DJ; Levin S; Tsai BS; Djurić SW; Widomski DL; Zemaitis JM; Shone RL; Bauer RF
    Agents Actions; 1989 Jun; 27(3-4):395-7. PubMed ID: 2552769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist.
    Kishikawa K; Matsunaga N; Maruyama T; Seo R; Toda M; Miyamoto T; Kawasaki A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():407-10. PubMed ID: 1847777
    [No Abstract]   [Full Text] [Related]  

  • 60. trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor.
    Reiter LA; Koch K; Piscopio AD; Showell HJ; Alpert R; Biggers MS; Chambers RJ; Conklyn MJ; Cooper K; Cortina SR; Dibrino JN; Dominy BW; Farrell CA; Hingorani GP; Martinelli GJ; Ramchandani M; Wright KF
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1781-6. PubMed ID: 9873433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.